Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation
Background and objectives: A new pandemic has emerged across the world:Covid-19. Covid-19 has affected hundreds of millions of people globally. To stop the spread of the virus and gain a mass immunity several vaccines have been developed. BNT162b2-mRNA-vaccine has been shown to be largely effective...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
PAGEPress Publications
2022-02-01
|
| Col·lecció: | Mediterranean Journal of Hematology and Infectious Diseases |
| Matèries: | |
| Accés en línia: | http://mjhid.org/index.php/mjhid/article/view/4820 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|